A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival
- PMID: 20424130
- PMCID: PMC2865569
- DOI: 10.1158/1940-6207.CAPR-09-0216
A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival
Abstract
The role of selenium in prostate cancer (PCa) risk remains controversial, but many epidemiologic studies suggest an inverse association with more aggressive disease. A recently discovered selenoprotein, SEP15, which is highly expressed in the prostate, may play a role either independently or by modifying the effects of selenium. We genotyped four common single-nucleotide polymorphisms capturing common variation (frequency >5%; R(2) > 0.8) within SEP15, as well as rs5859 in the 3' untranslated region, previously reported to reduce the efficiency of selenium incorporation into SEP15. We examined the association of these single-nucleotide polymorphisms with PCa risk and PCa-specific mortality, as well as their interactions with plasma selenium levels, in the Physicians' Health Study. In this nested case-control study (1,286 cases and 1,267 controls), SEP15 polymorphisms were not significantly associated with PCa risk. However, among the cases, three variants were significantly associated with PCa-specific mortality [rs479341 hazard ratio (HR), 1.94; 95% confidence interval (95% CI), 1.15-3.25; rs1407131 HR, 2.85; 95% CI, 1.45-5.59; rs561104 HR, 1.54; 95% CI, 1.12-2.11] with a recessive model. Additionally, rs561104 significantly modified the association of plasma selenium with PCa survival (P(interaction) = 0.02); an inverse relationship of high levels of selenium with PCa mortality was apparent only among those without the increased risk genotype. This study provides evidence that SEP15 genetic variation may influence PCa mortality. Additionally, the association of selenium with PCa mortality was modified by a variant, suggesting the possibility that some men with PCa may benefit more from selenium than others, depending on their genotype.
Figures
Comment in
-
Is prostate cancer prevention with selenium all in the genes?Cancer Prev Res (Phila). 2010 May;3(5):576-8. doi: 10.1158/1940-6207.CAPR-10-0072. Epub 2010 Apr 27. Cancer Prev Res (Phila). 2010. PMID: 20424133 Review.
References
-
- Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998;90:1219–24. - PubMed
-
- Li H, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst. 2004;96:696–703. - PubMed
-
- Clark LC, Combs GF, Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial Nutritional Prevention of Cancer Study Group. Jama. 1996;276:1957–63. - PubMed
-
- Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003;91:608–12. - PubMed
-
- Klein EA, Thompson IM, Lippman SM, et al. SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer Prostatic Dis. 2000;3:145–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA-40360/CA/NCI NIH HHS/United States
- CA-34944/CA/NCI NIH HHS/United States
- HL-34595/HL/NHLBI NIH HHS/United States
- HL-26490/HL/NHLBI NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
- CA-42182/CA/NCI NIH HHS/United States
- R25 CA098566/CA/NCI NIH HHS/United States
- T32 CA009001/CA/NCI NIH HHS/United States
- CA-097193/CA/NCI NIH HHS/United States
- R01 CA040360/CA/NCI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- R01 CA042182/CA/NCI NIH HHS/United States
- R01 HL026490/HL/NHLBI NIH HHS/United States
- R01 CA034944/CA/NCI NIH HHS/United States
- R01 CA141298/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical